Quinolone Resistance in E. coli from IBD Patients in Iran
Author Information
Author(s): Samira Alipour, Mina Owrang, Mohsen Rajabnia, Meysam Olfatifar, Hossein Kazemian, Hamidreza Houri
Primary Institution: Shahid Beheshti University of Medical Sciences
Hypothesis
This study aimed to explore the frequency of fluoroquinolone resistance and the presence of associated resistance genes in Escherichia coli isolates obtained from intestinal biopsies of patients with IBD in Iran.
Conclusion
A significant number of patients with IBD carry quinolone-resistant E. coli, which may affect disease progression and contribute to complications.
Supporting Evidence
- 57% of E. coli isolates showed phenotypic resistance to at least one type of quinolone.
- Plasmid-mediated quinolone resistance genes were detected in E. coli strains linked to both UC and CD.
- There was a significant positive correlation between ciprofloxacin-resistant E. coli and prior ciprofloxacin therapy.
Takeaway
Many people with inflammatory bowel disease have bacteria that are resistant to a type of antibiotic called quinolone, which can make their condition worse.
Methodology
The study involved isolating E. coli from biopsies of patients with IBD and performing phenotypic and molecular analyses to assess antibiotic resistance.
Limitations
The study did not investigate mutation-based resistance mechanisms and was cross-sectional, limiting causal inferences.
Participant Demographics
121 patients with IBD, including 99 with ulcerative colitis and 22 with Crohn's disease, with a median age of 36.08 years for UC and 39.32 years for CD.
Statistical Information
P-Value
p<0.001
Confidence Interval
0.46−2.52
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website